Financials
Financial year 2025
DR. CREVITS ILSE from Tielt, company number BE0889276697, closed financial year 2025 with a result of € 173,846 after tax. For that financial year DR. CREVITS ILSE recorded a gross margin of € 296,542 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 223,558 to € 173,846. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 23, 2026.
€ 1.1 million
▲ 18% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 173,846
▼ 22% vs 2024
Profit after tax over the fiscal year.
€ 830,207
▲ 78% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
0 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 24,127
▼ 5% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 29,514
▼ 28% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 15,631
▲ € 13,590 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,443
▼ 41% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 285,907 | € 278,020 | € 323,603 | € 296,542 | ▼ 8% |
| Profit after taxes | € 148,809 | € 137,885 | € 223,558 | € 173,846 | ▼ 22% |
| Equity | € 1,118,668 | € 1,112,596 | € 954,207 | € 1,127,221 | ▲ 18% |
| Total debts | € 427,671 | € 541,373 | € 441,115 | € 450,161 | ▲ 2% |
| Cash | € 1,041,715 | € 1,110,430 | € 467,350 | € 830,207 | ▲ 78% |
| Land & buildings | € 16,647 | € 3,329 | - | - | |
| Retained profit | € 910,544 | € 1,047,596 | € 889,207 | € 1,062,221 | ▲ 19% |
| Dividend | € 800 | € 833 | € 381,947 | € 833 | ▼ € 381,114 |
| Balance sheet total | € 1,546,339 | € 1,653,969 | € 1,395,322 | € 1,577,381 | ▲ 13% |
Key figures of DR. CREVITS ILSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. CREVITS ILSE?
What happened at DR. CREVITS ILSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 173,846 (▼ 22% vs 2024). filed late Source: NBB ↗
- Ilse CREVITS became a director. NBB
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 148,809 profit in 2022 to € 173,846 profit in 2025.
Paid € 298,771 in corporate taxes since 2022.
Best year ever: 2024, with € 223,558 profit.
Paid out € 384,413 in dividends to the owners in total.
Management
Behind DR. CREVITS ILSE is Ilse CREVITS. Ilse CREVITS is also behind ARTSEN RADIOLOGIE AZ DELTA.
Directors
According to the 2025 annual accounts
since 2022
Establishments
Establishment units
Physical locations of this company
Sint-Janstraat 36
8700 Tielt
Wilgenstraat 2
8800 Roeselare
Active since 8 May 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0889.276.697
- VAT number
- BE 0889.276.697
- Registered office
- Sint-Janstraat 36, 8700 Tielt
- Names & denominations
- DR. CREVITS ILSE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 May 2007
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Activiteiten van huisartspraktijken
Activiteiten van medisch specialisten
Overige zakelijke dienstverlening, neg